Cargando…
_version_ 1784725696366510080
author Hadji, Maryam
Rashidian, Hamideh
Marzban, Maryam
Naghibzadeh-Tahami, Ahmad
Gholipour, Mahin
Mohebbi, Elham
Safari-Faramani, Roya
Seyyedsalehi, Monireh Sadat
Hosseini, Bayan
Bakhshi, Mahdieh
Alizadeh-Navaei, Reza
Ahmadi, Lida
Rezaianzadeh, Abbas
Moradi, Abdolvahab
Ansari-Moghaddam, Alireza
Nejatizadeh, Azim
ShahidSales, Soodabeh
Zohrabi, Farshad
Mohammadi, Reza
Nowroozi, Mohammad Reza
Poustchi, Hossein
Nasrollahzadeh, Dariush
Najafi, Farid
Haghdoost, Ali Akbar
Rahimi-Movaghar, Afarin
Etemadi, Arash
Mohagheghi, Mohammad Ali
Malekzadeh, Reza
Brennan, Paul
Schüz, Joachim
Boffetta, Paolo
Weiderpass, Elisabete
Kamangar, Farin
Zendehdel, Kazem
Pukkala, Eero
author_facet Hadji, Maryam
Rashidian, Hamideh
Marzban, Maryam
Naghibzadeh-Tahami, Ahmad
Gholipour, Mahin
Mohebbi, Elham
Safari-Faramani, Roya
Seyyedsalehi, Monireh Sadat
Hosseini, Bayan
Bakhshi, Mahdieh
Alizadeh-Navaei, Reza
Ahmadi, Lida
Rezaianzadeh, Abbas
Moradi, Abdolvahab
Ansari-Moghaddam, Alireza
Nejatizadeh, Azim
ShahidSales, Soodabeh
Zohrabi, Farshad
Mohammadi, Reza
Nowroozi, Mohammad Reza
Poustchi, Hossein
Nasrollahzadeh, Dariush
Najafi, Farid
Haghdoost, Ali Akbar
Rahimi-Movaghar, Afarin
Etemadi, Arash
Mohagheghi, Mohammad Ali
Malekzadeh, Reza
Brennan, Paul
Schüz, Joachim
Boffetta, Paolo
Weiderpass, Elisabete
Kamangar, Farin
Zendehdel, Kazem
Pukkala, Eero
author_sort Hadji, Maryam
collection PubMed
description BACKGROUND: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC. METHOD: In this multi-centre case-referent study in Iran, 717 BC cases and 3477 referents were recruited to the study from May 2017 until July 2020. Detailed histories of opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure adjusted odds ratio (OR) and 95% confidence intervals (CI). The ORs were adjusted for age, gender, place of residence and pack-years of cigarette smoking. RESULTS: Regular opium consumption was associated with an increased risk of BC (OR 3.5, 95% CI: 2.8, 4.3) compared with subjects who never used opium. Compared with continuous users, the risk decreased to one-third for those who stopped opium more than 10 years ago. The adjusted OR for those who used both crude opium (teriak) and opium juice was 7.4 (95% CI: 4.1, 13.3). There was a joint effect of opium and tobacco (OR for users of both opium and tobacco 7.7, 95% CI: 6.0, 9.7). CONCLUSIONS: Regular opium use is associated with an approximately 4-fold risk for BC. The OR decreases along with the increasing time since stopping opium use.
format Online
Article
Text
id pubmed-9189939
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91899392022-06-14 Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran Hadji, Maryam Rashidian, Hamideh Marzban, Maryam Naghibzadeh-Tahami, Ahmad Gholipour, Mahin Mohebbi, Elham Safari-Faramani, Roya Seyyedsalehi, Monireh Sadat Hosseini, Bayan Bakhshi, Mahdieh Alizadeh-Navaei, Reza Ahmadi, Lida Rezaianzadeh, Abbas Moradi, Abdolvahab Ansari-Moghaddam, Alireza Nejatizadeh, Azim ShahidSales, Soodabeh Zohrabi, Farshad Mohammadi, Reza Nowroozi, Mohammad Reza Poustchi, Hossein Nasrollahzadeh, Dariush Najafi, Farid Haghdoost, Ali Akbar Rahimi-Movaghar, Afarin Etemadi, Arash Mohagheghi, Mohammad Ali Malekzadeh, Reza Brennan, Paul Schüz, Joachim Boffetta, Paolo Weiderpass, Elisabete Kamangar, Farin Zendehdel, Kazem Pukkala, Eero Int J Epidemiol Cancer BACKGROUND: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC. METHOD: In this multi-centre case-referent study in Iran, 717 BC cases and 3477 referents were recruited to the study from May 2017 until July 2020. Detailed histories of opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure adjusted odds ratio (OR) and 95% confidence intervals (CI). The ORs were adjusted for age, gender, place of residence and pack-years of cigarette smoking. RESULTS: Regular opium consumption was associated with an increased risk of BC (OR 3.5, 95% CI: 2.8, 4.3) compared with subjects who never used opium. Compared with continuous users, the risk decreased to one-third for those who stopped opium more than 10 years ago. The adjusted OR for those who used both crude opium (teriak) and opium juice was 7.4 (95% CI: 4.1, 13.3). There was a joint effect of opium and tobacco (OR for users of both opium and tobacco 7.7, 95% CI: 6.0, 9.7). CONCLUSIONS: Regular opium use is associated with an approximately 4-fold risk for BC. The OR decreases along with the increasing time since stopping opium use. Oxford University Press 2022-03-04 /pmc/articles/PMC9189939/ /pubmed/35244716 http://dx.doi.org/10.1093/ije/dyac031 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the International Epidemiological Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer
Hadji, Maryam
Rashidian, Hamideh
Marzban, Maryam
Naghibzadeh-Tahami, Ahmad
Gholipour, Mahin
Mohebbi, Elham
Safari-Faramani, Roya
Seyyedsalehi, Monireh Sadat
Hosseini, Bayan
Bakhshi, Mahdieh
Alizadeh-Navaei, Reza
Ahmadi, Lida
Rezaianzadeh, Abbas
Moradi, Abdolvahab
Ansari-Moghaddam, Alireza
Nejatizadeh, Azim
ShahidSales, Soodabeh
Zohrabi, Farshad
Mohammadi, Reza
Nowroozi, Mohammad Reza
Poustchi, Hossein
Nasrollahzadeh, Dariush
Najafi, Farid
Haghdoost, Ali Akbar
Rahimi-Movaghar, Afarin
Etemadi, Arash
Mohagheghi, Mohammad Ali
Malekzadeh, Reza
Brennan, Paul
Schüz, Joachim
Boffetta, Paolo
Weiderpass, Elisabete
Kamangar, Farin
Zendehdel, Kazem
Pukkala, Eero
Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title_full Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title_fullStr Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title_full_unstemmed Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title_short Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran
title_sort opium use and risk of bladder cancer: a multi-centre case-referent study in iran
topic Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189939/
https://www.ncbi.nlm.nih.gov/pubmed/35244716
http://dx.doi.org/10.1093/ije/dyac031
work_keys_str_mv AT hadjimaryam opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT rashidianhamideh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT marzbanmaryam opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT naghibzadehtahamiahmad opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT gholipourmahin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT mohebbielham opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT safarifaramaniroya opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT seyyedsalehimonirehsadat opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT hosseinibayan opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT bakhshimahdieh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT alizadehnavaeireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT ahmadilida opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT rezaianzadehabbas opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT moradiabdolvahab opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT ansarimoghaddamalireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT nejatizadehazim opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT shahidsalessoodabeh opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT zohrabifarshad opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT mohammadireza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT nowroozimohammadreza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT poustchihossein opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT nasrollahzadehdariush opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT najafifarid opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT haghdoostaliakbar opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT rahimimovagharafarin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT etemadiarash opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT mohagheghimohammadali opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT malekzadehreza opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT brennanpaul opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT schuzjoachim opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT boffettapaolo opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT weiderpasselisabete opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT kamangarfarin opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT zendehdelkazem opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran
AT pukkalaeero opiumuseandriskofbladdercanceramulticentrecasereferentstudyiniran